Loading clinical trials...

Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD | Clinical Trials | Clareo Health

COMPLETEDNA

Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD

A Prospective Randomized Trial to Asses the Efficacy of an Early Psychiatric Counseling Compared to Usual Care in a Cohort of Patients Hospitalized for an Acute Exacerbation of COPD in Prevention of Re-exacerbation

NCT01520376•Nestor Soler Porcar, MD, PhD

View on ClinicalTrials.gov

Summary

This study will try to elucidate wheter the impact of a psychiatric intervention in patients hospitalized because an acute exacerbation of COPD and anxiety/depression and reconsulting at 1 and 6 month after discharge.

Eligibility

Age

40 - 90 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Men and women of any ethnic group
•Above 40 years old
•Diagnose with Chronic Obstructive Pulmonary disease (COPD) according to the ATS/ERS guidelines
•Acute exacerbation of COPD according to the following criteria:
•a) Cyanosis b) Obnubilations or mental confusion d) Respiratory Rate above 25 per minute e) Failure of ambulatory treatment f) Co-morbidities that worsens respiratory condition g) Dyspnea

Exclusion Criteria

•Less than 6 months expectancy of life
•Needing of mechanical ventilation
•Severe cardiovascular disease
•Pregnancy
•Previous diagnosis of depression/anxiety

Locations (1)

Fundacio Clinic Per la Recerca Biomèdica - Hospital Clinic de Barcelona

Barcelona, Catalonia, Spain

Key Dates

Start Date

October 1, 2011

Primary Completion Date

October 1, 2013

Completion Date

April 1, 2014

Last Updated

July 6, 2018

Enrollment

169

ACTUAL participants

Conditions

Chronic Obstructive Pulmonary DiseaseAnxietyDepression

Interventions

Counselling

BEHAVIORAL

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

NCT07360600

ParentsChildren With Disabilities+2 more

View study

RECRUITINGPHASE3

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

NCT06793397

Major Depressive Disorder (MDD)Depression in Adults+4 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 6, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Anxiety and Depression in Patients Hospitalizes for an Acute Exacerbation of COPD

Inclusion Criteria

Exclusion Criteria

ACT Together: Implementing a Web-Based Program With Brief Coaching for Parents of Children With Disabilities in Pediatric Outpatient Clinics

A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

cfMSC Stem Cell Therapy Targeting COPD

Readiness and Progress in Emotion Regulation Therapy

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression